新浪科技讯 1月9日上午消息，近日，京东健康互联网医疗业务负责人透露，京东互联网医院作为国内 首批取得牌照的独立设置型互联网医院之一，日均问诊咨询量超过50万，客户满意度达98.9%。 在持续提升综合服务能力的同时，京东互联网医院也重点加强了专科专病服务体系的建设。目前已陆续 升级皮肤医院、精神心理中心及中医院，并于2025年新增男科与肿瘤专科，与全国知名专家共建专病工 作室。 如今，京东健康已建成覆盖"医、检、诊、药"的一站式闭环服务。从线上问诊、检验单开具、护士上门 检测，到报告解读、药品配送，用户足不出户即可完成全流程诊疗。此外，还支持全国多城市的影像检 查预约，进一步拓展了服务边界。 该负责人提到，2025年，药械+医疗服务的闭环链接进一步拓展。此外，在助力医疗器械品牌成长方 面，京东互联网医院已形成从医生沟通、用户管理到医院场景触达等全链路支持体系。 新浪科技讯 1月9日上午消息，近日，京东健康互联网医疗业务负责人透露，京东互联网医院作为国内 首批取得牌照的独立设置型互联网医院之一，日均问诊咨询量超过50万，客户满意度达98.9%。 在持续提升综合服务能力的同时，京东互联网医院也重点加强了专科专病服 ...

Core Viewpoint - Sipai Health (00314) reported a significant strategic transformation aimed at enhancing its commercial medical insurance and healthcare service network, leading to improved financial performance despite a net loss [1][2] Group 1: Financial Performance - For the six months ending June 30, 2025, the company achieved total revenue of RMB 1.224 billion, with a gross profit of RMB 176 million and a gross margin of 14.4% [1] - The normalized net loss was RMB 11.996 million, translating to a loss per share of RMB 0.12 [1] - The gross margin improved by 4.7 percentage points year-on-year, indicating effective cost management and operational efficiency [2] Group 2: Strategic Initiatives - The company is focusing on upgrading its business model to become a comprehensive provider of commercial medical payment and healthcare services, targeting corporate employee health management needs [1] - Strategic adjustments were made to enhance the scale and service network of the corporate health insurance business, alongside ongoing structural adjustments and management optimizations [2] - The strategic reorganization of specialty pharmacy and health insurance segments has led to a clearer path towards achieving profitability goals and sustainable growth [2]

Core Viewpoint - Sipai Health (00314) reported a significant strategic transformation and improvement in financial performance, with a focus on commercial medical insurance and healthcare services [1][2] Financial Performance - For the six months ending June 30, 2025, the company achieved total revenue of RMB 1.224 billion, with a gross profit of RMB 176 million and a gross margin of 14.4% [1] - The normalized net loss was RMB 11.996 million, translating to a loss per share of RMB 0.12 [1] - The gross margin improved by 4.7 percentage points year-on-year, indicating effective cost management and operational efficiency [2] Strategic Initiatives - The company is undergoing a strategic upgrade to become a comprehensive commercial medical payment and service network, focusing on employee healthcare and management needs [1] - A strategic adjustment was made to concentrate resources on scaling the corporate health insurance business and enhancing the service network [2] - The company implemented a strategic restructuring of its specialty pharmacy and health insurance segments, leading to a significant reduction in normalized net loss by 59.6% year-on-year [2]

Group 1 - The company reported total revenue of RMB 1.224 billion and a gross profit of RMB 176 million for the six months ending June 30, 2025, with a gross margin of 14.4% [1] - The normalized net loss was RMB 11.996 million, translating to a loss per share of RMB 0.12 [1] - The company is undergoing a strategic transformation to become a commercial medical payment and healthcare service network, focusing on employee medical security and health management needs [1] Group 2 - The company has made strategic adjustments to enhance its commercial health insurance business, focusing on scaling enterprise health insurance and building service networks [2] - A strategic restructuring of specialty pharmacy and health insurance segments has led to a significant increase in gross margin by 4.7 percentage points to 14.4%, and a substantial reduction in normalized net loss by 59.6% [2] - The company anticipates continued growth in business scale and improvement in profitability, supported by ongoing policy benefits and enhanced service capabilities [2]